Danaher Co. (NYSE:DHR) Receives Average Recommendation of “Buy” from Brokerages

Shares of Danaher Co. (NYSE:DHRGet Rating) have earned an average rating of “Buy” from the fifteen analysts that are presently covering the company, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $336.08.

Several equities research analysts have commented on DHR shares. UBS Group lowered their price objective on Danaher from $365.00 to $340.00 in a research report on Sunday, April 24th. William Blair reissued an “outperform” rating on shares of Danaher in a research note on Friday, April 22nd. Royal Bank of Canada raised Danaher from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $299.00 to $310.00 in a research note on Wednesday, June 1st. Wells Fargo & Company downgraded Danaher from an “overweight” rating to an “equal weight” rating and reduced their price objective for the company from $330.00 to $265.00 in a research note on Monday, April 25th. Finally, Robert W. Baird reduced their price objective on Danaher from $334.00 to $319.00 and set an “outperform” rating for the company in a research note on Friday, April 22nd.

In related news, EVP Joakim Weidemanis sold 6,500 shares of the firm’s stock in a transaction dated Monday, April 25th. The stock was sold at an average price of $255.74, for a total transaction of $1,662,310.00. Following the completion of the transaction, the executive vice president now directly owns 86,398 shares in the company, valued at approximately $22,095,424.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 11.20% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Norges Bank purchased a new position in Danaher in the fourth quarter valued at approximately $2,015,889,000. Castleview Partners LLC acquired a new position in Danaher in the fourth quarter valued at $4,077,000. UBS Asset Management Americas Inc. increased its stake in Danaher by 31.6% in the third quarter. UBS Asset Management Americas Inc. now owns 4,923,603 shares of the conglomerate’s stock valued at $1,498,942,000 after purchasing an additional 1,181,343 shares during the period. AustralianSuper Pty Ltd increased its stake in Danaher by 916.7% in the first quarter. AustralianSuper Pty Ltd now owns 1,168,431 shares of the conglomerate’s stock valued at $342,736,000 after purchasing an additional 1,053,502 shares during the period. Finally, Vanguard Group Inc. increased its stake in Danaher by 2.1% in the first quarter. Vanguard Group Inc. now owns 51,004,840 shares of the conglomerate’s stock valued at $14,961,250,000 after purchasing an additional 1,044,650 shares during the period. Institutional investors and hedge funds own 78.42% of the company’s stock.

Shares of NYSE DHR opened at $238.60 on Friday. The business’s 50 day moving average price is $257.56 and its 200 day moving average price is $280.00. The firm has a market cap of $173.48 billion, a P/E ratio of 27.62, a P/E/G ratio of 2.68 and a beta of 0.84. Danaher has a 52 week low of $233.71 and a 52 week high of $333.96. The company has a quick ratio of 1.27, a current ratio of 1.68 and a debt-to-equity ratio of 0.51.

Danaher (NYSE:DHRGet Rating) last released its quarterly earnings data on Thursday, April 21st. The conglomerate reported $2.76 EPS for the quarter, topping the consensus estimate of $2.65 by $0.11. Danaher had a return on equity of 18.64% and a net margin of 21.32%. The business had revenue of $7.69 billion for the quarter, compared to analyst estimates of $7.53 billion. During the same quarter in the prior year, the firm posted $2.52 EPS. The business’s quarterly revenue was up 11.6% compared to the same quarter last year. As a group, research analysts expect that Danaher will post 10.31 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 29th. Investors of record on Friday, June 24th will be issued a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 0.42%. The ex-dividend date is Thursday, June 23rd. Danaher’s dividend payout ratio (DPR) is 11.57%.

Danaher Company Profile (Get Rating)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.

Featured Articles

Analyst Recommendations for Danaher (NYSE:DHR)

Want More Great Investing Ideas?

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.